ILMN Stock to Gain From the Launch of Illumina Protein Prep Assay

Key Takeaways Illumina Protein Prep expands NGS proteomics at scale, powering multiomics studies and disease insights.Illumina Protein Prep uses SOMAmer technology to unlock insights across 9,500 human proteins for multiomics.SomaLogic deal positions Illumina to lead in proteomics and drive growth in its multiomics strategy.Illumina, Inc. (ILMN) recently announced the launch of Illumina Protein Prep, an assay designed to deliver superior performance for next-generation sequencing (NGS)-based proteomics disc ...